Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Conestoga's Micro Cap strategy returned 9.91% in Q4 but lagged benchmarks due to AI speculation favoring high-beta stocks. Alpha Teknova led gains on improving biotech conditions while Montrose Environmental declined on regulatory uncertainty. Despite 2024 underperformance, the firm maintains conviction in high-quality positioning and expects small cap outperformance ahead.
Full Quick Take
Conestoga's Micro Cap strategy returned 9.91% in Q4 but lagged benchmarks due to AI speculation favoring high-beta stocks. Alpha Teknova led gains on improving biotech conditions while Montrose Environmental declined on regulatory uncertainty. Despite 2024 underperformance, the firm maintains conviction in high-quality positioning and expects small cap outperformance ahead.
